XXII Earnings

XXII reported its earnings on 2026-02-17, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following XXII's earnings announcement on 2026-02-17, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, XXII's stock price tends to shift by an average of +8.12% in the 10 days leading up to earnings and -26.55% in the 10 days following, providing insight into potential market.

For , analysts estimate XXII’s annual revenue to reach , while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between XXII's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, XXII's stock price typically moves by +8.12% in the 10 days before its earnings and -26.55% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of .

The earnings call reveals several challenges: declining net revenue, increased losses, and market adoption hurdles for VLN products. Despite optimistic profitability guidance, the company's transition to higher-margin products is slow and costly. Management's lack of clarity in the Q&A adds uncertainty, and the potential for regulatory and competitive pressures further complicates the outlook. Without clear strategies to overcome these obstacles, the stock is likely to face negative pressure over the next two weeks.